Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, GenoLogics

GE Healthcare last week launched the HiTrap Capto IEX Selection Kit, a set of prepacked HiTrap 1-mL columns for selecting the best Capto ion exchange chromatography media for a given application.
Capto offers high-volume throughput with high capacity for fast and efficient purification of large amounts of protein, the company said in a statement. The HiTrap kits allow for fast, easy screening of three traditional and two multimodal ion exchange chromatography media before scale-up.
The kit comprises five different high-capacity ion exchange and multimodal ion exchange media based on the Capto highly rigid agarose base matrix.

GenoLogics this week launched Proteus 4.0 data management software.
Proteus 4.0 automates data capture from proteomics experiments and “seamlessly” tracks projects, samples, and results. It has “purposed instrument and analytical software integrations” and enhances analysis of contextually relevant protein and peptide comparisons, the company said in a statement. It also has a web interface allowing customers and external collaborators to submit samples and the laboratory to publish results.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.